Carrollton-based Gradalis, Inc., a clinical-stage biotechnology company developing personalized anti-cancer therapies, has named Steven D. Weinstein as its new chief executive officer. Weinstein brings more than 20 years as a …
biotech
UTA and the Texas A&M Engineering Experiment Station have opened a new biomanufacturing training and research hub at Pegasus Park focused on workforce training and early-stage biotech development. The National …
Curve Biosciences founder and CEO, Plano-born Ritish Patnaik, says “chronic diseases are on the rise, and healthcare costs are skyrocketing as a result.” From its newly established HQ at Pegasus …
Lantern Pharma Inc. (Nasdaq: LTRN) said it plans to launch a clinical trial in early 2026 for a rare pediatric brain cancer, following what it called an “optimistic meeting” with the …
University of Texas at Arlington computer science professor, Junzhou Huang, has secured $3.1 million in federal funding to tackle one of medicine’s most time-consuming challenges: figuring out which antibodies will …
UT Southwestern professor of biochemistry Steven McKnight, along with Dirk Görlich of the Max Planck Institute for Multidisciplinary Sciences in Germany, won the 2025 Albert Lasker Basic Medical Research Award …
Nationally ranked healthcare accelerator Health Wildcatters has named 11 startups to its newest class, marking what the Dallas-based program called another milestone in the region’s rise as a health innovation …
Mansfield Economic Development Corp. and Stallion Labs, whose headquarters is in Ahmedabad, struck a deal on an economic incentive and performance agreement, which was approved and the council July 14. …
Only a small fraction of drugs can cross the blood-brain barrier–the layer that protects the brain from harmful substances. Usually a good thing, it also makes it harder to treat …
A $30 million merger among Community Direct DX (CDx), Scienetix, and the R&D division of Advanta Genetics has formed McKinney-based OSPRI, a next-generation biotechnology company and “one of the world’s …